https://wikimd.com/index.php?action=history&feed=atom&title=Rhc80267 2026-04-22T03:55:20Z Revision history for this page on the wiki MediaWiki 1.44.2 https://wikimd.com/index.php?title=Rhc80267&diff=6416386&oldid=prev 2025-03-03T05:27:02Z

<p>CSV import</p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 05:27, 3 March 2025</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l27">Line 27:</td> <td colspan="2" class="diff-lineno">Line 27:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{{pharmacology-stub}}</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{{pharmacology-stub}}</div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">&lt;gallery&gt;</ins></div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">File:RHC80267.png|RHC80267</ins></div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">&lt;/gallery&gt;</ins></div></td></tr> </table>

Prab https://wikimd.com/index.php?title=Rhc80267&diff=5374821&oldid=prev 2024-03-08T18:33:00Z

<p>CSV import</p> <p><b>New page</b></p><div>&#039;&#039;&#039;Rhc80267&#039;&#039;&#039; is a [[chemical compound]] that is often used in [[pharmacology]] and [[biochemistry]]. It is a potent and selective inhibitor of [[adenylyl cyclase]], an enzyme that plays a crucial role in the [[cellular signaling]] pathways of many organisms.<br /> <br /> ==Chemical Structure==<br /> Rhc80267 is a [[diterpene]] derivative, meaning it is composed of four isoprene units and has a molecular formula of C20H34. Its chemical structure is characterized by a complex arrangement of carbon, hydrogen, and oxygen atoms, which contribute to its unique pharmacological properties.<br /> <br /> ==Pharmacological Action==<br /> Rhc80267 exerts its effects by inhibiting the activity of adenylyl cyclase, an enzyme that catalyzes the conversion of [[adenosine triphosphate]] (ATP) to [[cyclic adenosine monophosphate]] (cAMP). By blocking this conversion, Rhc80267 effectively disrupts the cAMP-dependent signaling pathways, which can have a wide range of effects on cellular function.<br /> <br /> ==Clinical Applications==<br /> Due to its ability to inhibit adenylyl cyclase, Rhc80267 has potential applications in the treatment of diseases that are characterized by overactive cAMP signaling. These include certain types of [[cancer]], [[cardiovascular disease]], and [[neurological disorders]]. However, more research is needed to fully understand the therapeutic potential of Rhc80267.<br /> <br /> ==Safety and Toxicity==<br /> Like all pharmacological agents, Rhc80267 has the potential to cause adverse effects. These can range from mild, such as nausea and headache, to severe, such as organ damage or death. Therefore, it is crucial that Rhc80267 is used under the supervision of a qualified healthcare professional.<br /> <br /> ==See Also==<br /> * [[Adenylyl cyclase]]<br /> * [[Cyclic adenosine monophosphate]]<br /> * [[Pharmacology]]<br /> * [[Biochemistry]]<br /> <br /> ==References==<br /> &lt;references /&gt;<br /> <br /> [[Category:Pharmacology]]<br /> [[Category:Biochemistry]]<br /> [[Category:Chemical compounds]]<br /> <br /> {{pharmacology-stub}}</div>

Prab